Immunic market cap
Witryna6 kwi 2024 · Immunic, Inc. meldet Ergebnis für das am 31. Dezember 2024 beendete Geschäftsjahr. 22.02. Immunic, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium mit einer Pipeline von selektiven oralen Immunologie-Therapien, die sich auf die Behandlung von chronischen Entzündungs- und … Witryna28 mar 2024 · Immunic has 4 employees across 2 locations. See insights on Immunic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Advanced. Products. ... Market Capitalization. $64.8 M. 2024-03-28. Immunic Summary. Company summary. Overview.
Immunic market cap
Did you know?
Witryna7 kwi 2024 · Latest Immunic Inc Stock News. As of April 06, 2024, Immunic Inc had a $68.8 million market capitalization, putting it in the 30th percentile of companies in the Biotechnology & Medical Research industry. Immunic Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. WitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush
WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net Witryna12 kwi 2024 · 5 analysts have issued 12 month price targets for Immunic's shares. Their IMUX share price forecasts range from $5.00 to $39.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 1,554.1% from the stock's current price.
Witryna10 kwi 2024 · At the end of the latest market close, Immunic Inc. (IMUX) was valued at $1.55. In that particular session, Stock kicked-off at the price of $1.54 while reaching the peak value of $1.55 and lowest value recorded on the day was $1.36. The stock current value is $1.39.Recently in News on April 5, 2024 WitrynaHistorical daily share price chart and data for Immunic since 2024 adjusted for splits. The latest closing stock price for Immunic as of February 27, 2024 is 1.89.. The all-time high Immunic stock closing price was 1332.40 on June 16, 2014.; The Immunic 52-week high stock price is 12.64, which is 568.8% above the current share price.; The …
WitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat...
Witryna10 sie 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications Group Melody Carey +1-917-322-2571 [email protected] SOURCE ... kitbeez wireless ear budsWitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ... m6 folding shotgun/rifleWitrynaInvista em Immunic, NASDAQ: IMUX Ação - Veja o preçário IMUX em tempo real. Comissões grátis online em investimentos em Immunic: compra ou venda Immunic Ação sem custos de comissão com a Trading 212. Tal como com qualquer investimento, o seu capital está em risco. Os investimentos podem cair e subir e poderá obter um … m6 godmother\u0027sWitrynaAs of February 2024 Immunic's TTM earnings are -$83.89 M. companies: 7,303 total market cap: $84.738 T. Global ranking; Ranking by countries. America ... The … m6fwm-tWitryna26 mar 2024 · 6.5%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: IMUX is more volatile than 75% of US … m6g morphineWitryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … kitbeez true wireless earbuds its a dollarWitryna6 kwi 2024 · Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC).. The company on Wednesday said data from the maintenance phase of … kit behavior tracking tool